# Amoeba

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amoeba

- Industry: Chemicals
- Headquarters: Lyon, France
- Website: www.amoeba-nature.com/
- Total disclosed funding: $2.8M
- Latest round: Series A (Jul 1, 2014)
- Investors on record: 5

## About

Founded in 2010 and based in Lyon, France, Amoeba develops Biomeba, a green biocide based on the amoeba which disrupts the growth of pathogenic microorganisms such as legionella, pseudomonas, listeria, Aeromonas hydrophilia,  Klebsiella pneuomoniae, E. coli, and Staphylococcus aureus in water.

## Funding rounds

- Series A, Jul 1, 2014, $0.9M — Auriga Partners
- Series A, Sep 21, 2012, $0.6M — Evolem, Rhone-Alpes Creation, Eurekap!
- Series A, May 17, 2011, $1.3M — Siparex, Rhone-Alpes Creation, Eurekap!

## Investors

- Siparex (https://capitalatlas.ai/funds/siparex) — Series A
- Rhone-Alpes Creation (https://capitalatlas.ai/funds/rhone-alpes-creation) — Series A
- Eurekap! (https://capitalatlas.ai/funds/eurekap) — Series A
- Evolem — Series A
- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series A